These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5651556)

  • 1. [On therapy of hepatic coma with metabolites of the urea cycle, glutamate and alpha-ketoglutarate].
    Meuret G; Beck K; Keul J; Gruenagel HH
    Dtsch Med Wochenschr; 1968 Jun; 93(24):1194-7. PubMed ID: 5651556
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contribution to the treatment of portal systemic encephalopathy (author's transl)].
    Blahníková L; Horký J; Pechar J; Honzák R; Vosmík J
    Cesk Gastroenterol Vyz; 1978 Dec; 32(8):486-93. PubMed ID: 737756
    [No Abstract]   [Full Text] [Related]  

  • 3. [1 (+) ornithine alpha ketoglutarate in hepatic encephalopathy].
    Paris J; Merveille P; Molimard R
    Presse Med (1893); 1970 Jun; 78(30):1367-8. PubMed ID: 5421555
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hepatic coma.
    Spellberg MA
    Am J Gastroenterol; 1969 Feb; 51(2):118-28. PubMed ID: 4887357
    [No Abstract]   [Full Text] [Related]  

  • 5. Ornicetil on encephalopathy. Effect of ornicetil (ornithine alpha-ketoglutarate) on encephalopathy in patients with acute and chronic liver disease.
    Chainuvati T; Plengvanit U; Viranuvatti V
    Acta Hepatogastroenterol (Stuttg); 1977 Dec; 24(6):434-9. PubMed ID: 602619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-ketoglutarate and glutamate content of the rat brain in experimental hepatic coma].
    Hilgier W
    Neuropatol Pol; 1980; 18(1):121-6. PubMed ID: 7383346
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of experimental and clinical hyperammonaemia with ornithine-alpha-ketoglutarate].
    Szám I; Szentner J; Hegedüs-Wein I; Vass A; Szilárd T
    Wien Med Wochenschr; 1974 May; 124(20):319-25. PubMed ID: 4829691
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hepatic cirrhosis and hepatic coma with drugs having the capacity of lowering the blood ammonia levels].
    Müting D
    Clin Ter; 1967 Aug; 42(4):289-97. PubMed ID: 5608820
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of alpha-oxoglutarate on the development of hepatogenic gliopathy in rats with portacaval shunt].
    Mossakowski MJ; Pronaszko-Kurczyńska AP; Rózga J; Paluszkiewicz R
    Neuropatol Pol; 1977; 15(3):317-25. PubMed ID: 896050
    [No Abstract]   [Full Text] [Related]  

  • 10. Hippocampal glutamate release after porta cava anastomosis: reduced sensitivity to ammonia inhibition.
    Hamberger A; Hedquist B; Lundborg H; Nyström B
    J Neurosci Res; 1980; 5(4):313-22. PubMed ID: 7431434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral amino acid metabolism in hepatic coma.
    Berl S
    Exp Biol Med; 1971; 4():71-84. PubMed ID: 5162461
    [No Abstract]   [Full Text] [Related]  

  • 12. Glutamic acid in hepatic coma following portacaval anastomosis.
    RICHARDSON JE; MOFFATT M
    Lancet; 1953 Sep; 265(6785):570-1. PubMed ID: 13098005
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of ornighine alpha-ketoglutarate on hyperammoniemia in the cirrhotic patient].
    Michel H; Ogé P; Bertrand L
    Presse Med (1893); 1971 Apr; 79(19):867-8. PubMed ID: 5576498
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of arginine malate in experimental and clinical hyperammonemia].
    Szãm I; Szentner J; Hegedüs-Wein I; Vass A
    Int J Clin Pharmacol; 1972 Aug; 6(3):260-5. PubMed ID: 4648469
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new therapeutic principle in hepatic coma: parenteral supply of neutral amino acids].
    Funovics J; Wesdorp RI; Keane J; James JH; Fischer JE
    Langenbecks Arch Chir; 1976; Suppl():95-8. PubMed ID: 829604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic coma after portacaval anastomosis in cirrhotics with serious digestive hemorrhages (28 cases)].
    Ciobanu M; Papahagi E; Popovici Z; Ciurel M
    Arch Fr Mal App Dig; 1966; 55(7):675-84. PubMed ID: 5296823
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of sodium glutamate on hepatic coma.
    WEBSTER LT; DAVIDSON CS
    J Clin Invest; 1956 Feb; 35(2):191-9. PubMed ID: 13286337
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hepatic encephalopathy after portal shunt in the patient with cirrhosis].
    Grange D; Bismuth H
    Arch Fr Mal App Dig; 1975; 64(3):257-69. PubMed ID: 1108827
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].
    Butti A; Bianco S; Bergonzi P; Cagossi M; Civello IM; Borzone A; Nanni G; Pigliucci GM
    Chir Patol Sper; 1975 Apr; 23(2):77-95. PubMed ID: 1140038
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy.
    Lam KC; Tall AR; Goldstein GB; Mistilis SP
    Scand J Gastroenterol; 1973; 8(6):465-72. PubMed ID: 4589374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.